Summarized by Masters of Longevity from Science Daily - Health & Medicine.
A phase II single-arm trial found improved cognitive complaints and less fatigue.
Key Takeaways
- Enol-oxaloacetate reduced self-reported cognitive complaints in survivors.
- The phase II single-arm study tested the supplement for persistent fatigue.
- Efficacy is unproven; randomized trials are still required.
